NeurologyLive® Brain Games: March 13, 2022
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is sleep disorders.
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions are brought to you by Anita Shelgikar, MD, MHPE, FAASM, and will include the theme of sleep disorders.
Interested in submitting quiz questions? Contact our managing editor, Matt Hoffman, via email: mhoffman@neurologylive.com.
Which medication has the strongest evidence-based recommendation as a treatment of idiopathic hypersomnia in adults?
Which modality should be used for the diagnosis of obstructive sleep apnea (OSA) in patients with potential respiratory muscle weakness due to neuromuscular condition?
Which of the following are recommended to be given with initiation of positive airway pressure (PAP) therapy in adults with OSA?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Perispinal Etanercept Shows No Efficacy in Treating Chronic Stroke
September 16th 2025
- Current Challenges and New Opportunities Ahead for Women in Neurology
September 15th 2025
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025